Clinical trials
Observational Lymphoma, B-Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| ADC Therapeutics S.A. | 1 |
| AIDS Malignancy Consortium | 1 |
| Adicet Therapeutics | 1 |
| Caribou Biosciences, Inc. | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Children's Oncology Group | 1 |
| Cogent Biosciences, Inc. | 1 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 17 |
| Lymphoma, Non-Hodgkin | 8 |
| Lymphoma | 6 |
| Multiple Myeloma | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Hematologic Neoplasms | 4 |
| Lymphoma, Follicular | 4 |
| Burkitt Lymphoma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.